Recursion Pharmaceuticals, Inc. (RXRX)
3.605
+0.14
(+4.04%)
USD |
NASDAQ |
Oct 19, 16:00
3.62
+0.02
(+0.42%)
After-Hours: 17:23
Recursion Pharmaceuticals Cash from Operations (Annual) : -371.81M for Dec. 31, 2025
Cash from Operations (Annual) Chart
Historical Cash from Operations (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | -371.81M |
| December 31, 2024 | -359.17M |
| December 31, 2023 | -287.78M |
| December 31, 2022 | -83.52M |
| Date | Value |
|---|---|
| December 31, 2021 | -158.61M |
| December 31, 2020 | -45.40M |
| December 31, 2019 | -57.04M |
Cash From Operations Definition
Represents the net cash flow from the company's business operations.
Cash from Operations (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Operations (Annual) Benchmarks
| Absci Corp. | -92.92M |
| Twist Bioscience Corp. | -47.63M |
| Editas Medicine, Inc. | -165.24M |
| Amgen, Inc. | 9.958B |
| Halozyme Therapeutics, Inc. | 651.56M |